Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	1800-1801
Number of pages	2
Journal	New England Journal of Medicine
Volume	375
Issue number	18
DOIs	https://doi.org/10.1056/NEJMc1611290
Publication status	Published - 3-Nov-2016

Access to Document

@article{8f314e988c6e4cc29c2843be867f25f9,

title = "Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes",

author = "Hans-Henrik Parving and Hiddo Lambers-Heerspink and {de Zeeuw}, Dick",

year = "2016",

month = nov,

day = "3",

doi = "10.1056/NEJMc1611290",

language = "English",

volume = "375",

pages = "1800--1801",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOC",

number = "18",

}

TY - JOUR

T1 - Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

AU - Parving, Hans-Henrik

AU - Lambers-Heerspink, Hiddo

AU - de Zeeuw, Dick

PY - 2016/11/3

Y1 - 2016/11/3

U2 - 10.1056/NEJMc1611290

DO - 10.1056/NEJMc1611290

M3 - Letter

C2 - 28106974

SN - 0028-4793

VL - 375

SP - 1800

EP - 1801

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 18

ER -